Effects of compound probiotics on the weight, immunity performance and fecal microbiota of forest musk deer

Sci Rep. 2019 Dec 16;9(1):19146. doi: 10.1038/s41598-019-55731-5.

Abstract

Probiotics are intended to provide health benefits when consumed, generally by improving or restoring the gut flora. The health problems of forest musk deer (FMD, Moschus berezovskii), a threatened species currently under conservation, restrict the development of captive musk deer. This study was conducted with the aim of analyzing the effects of forest musk deer compound probiotics (FMDPs) on weight, immunity performance and fecal microbiota in FMD by measuring average daily weight gain (ADG) and immune-related factors and by using high-throughput 16S rRNA sequencing to investigate differences in the fecal microbiota among the control group (4 samples), treatment group A (4 samples) and treatment group B (4 samples). The results showed that the ADG of treatment groups A and B was significantly higher than that of the control group (p = 0.032, p = 0.018). The increase in IgA and IgG levels in treatment group B was significantly higher than that in the control group (p = 0.02, p = 0.011). At the phylum and genus levels, the difference in bacterial community structure was significant between treatment group B and the control group. Both the alpha diversity and beta diversity results showed significant differences in the microbiota of FMD before and after FMDP feeding. In summary, the results indicated that FMDPs could promote the growth of growing FMD, improve immunity and balance the role of intestinal microbes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biodiversity
  • Body Weight / drug effects*
  • Colony Count, Microbial
  • Deer / immunology*
  • Deer / microbiology*
  • Feces / microbiology*
  • Feeding Behavior
  • Forests*
  • Lactobacillales / drug effects
  • Lactobacillales / growth & development
  • Microbiota / drug effects*
  • Phylogeny
  • Principal Component Analysis
  • Probiotics / pharmacology*
  • RNA, Ribosomal, 16S / genetics

Substances

  • RNA, Ribosomal, 16S